PropertyValue
?:abstract
  • With the accumulation of observational data showing association of metabolic comorbidities with adverse outcomes from COVID‐19, there is a need to disentangle the contributions of pre‐existing macro‐ and microvascular disease, obesity and glycaemia. This article outlines the complex mechanistic and clinical interplay between diabetes and COVID‐19, the clinical and research questions that arise from these; and the types of studies needed to answer them. The authors are clinicians and academics working in diabetes and obesity medicine, but the article is pitched to an audience of generalists with clinical experience or interest in management of COVID‐19. This article is protected by copyright. All rights reserved.
?:creator
?:doi
  • 10.1111/dom.14134
?:doi
?:journal
  • Diabetes_Obes_Metab
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/f6a15bdbf5d45eeafc6fff3454d2909e7e761591.json
?:pmcid
?:pmid
?:pmid
  • 32627299.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Diabetes, Obesity and COVID‐19: A Complex Interplay
?:type
?:year
  • 2020-07-06

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/aar38bo6>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/aar38bo6>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all